---
title: "Imatinib - Pdgfra-Associated Chronic Eosinophilic Leukemia"
sidebar: mydoc_sidebar
permalink: db00619-mesh-c580364-1.html
toc: false 
---


Path ID: `DB00619_MESH_C580364_1`
{% include image.html url="images/db00619-mesh-c580364-1.png" file="db00619-mesh-c580364-1.png" alt="db00619-mesh-c580364-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D000068877">MESH:D000068877 </a> | imatinib | Drug |
| <a href="https://identifiers.org/UniProt:P16234">UniProt:P16234 </a> | Platelet-derived growth factor receptor alpha | Protein |
| <a href="https://identifiers.org/GO:0048008">GO:0048008 </a> | platelet-derived growth factor receptor signaling pathway | BiologicalProcess |
| <a href="https://identifiers.org/GO:0008283">GO:0008283 </a> | cell population proliferation | BiologicalProcess |
| <a href="https://identifiers.org/HP:0001880">HP:0001880 </a> | Eosinophilia | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:C580364">MESH:C580364 </a> | Pdgfra-Associated Chronic Eosinophilic Leukemia | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Imatinib | DECREASES ACTIVITY OF | Platelet-Derived Growth Factor Receptor Alpha |
| Platelet-Derived Growth Factor Receptor Alpha | POSITIVELY REGULATES | Platelet-Derived Growth Factor Receptor Signaling Pathway |
| Platelet-Derived Growth Factor Receptor Signaling Pathway | POSITIVELY CORRELATED WITH | Cell Population Proliferation |
| Cell Population Proliferation | POSITIVELY CORRELATED WITH | Eosinophilia |
| Eosinophilia | MANIFESTATION OF | Pdgfra-Associated Chronic Eosinophilic Leukemia |
|---------|-----------|---------|

Comment: The disease is also known as Chronic eosinophilic leukemia as per the original file. The malignancy is driven by FIP1L1-PDGFRA fusion genes (https://en.wikipedia.org/wiki/FIP1L1#FIP1L1-PDGFRA_fusion_genes).

Reference: 
  - [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate)
  - [https://go.drugbank.com/drugs/DB00619#BE0000205](https://go.drugbank.com/drugs/DB00619#BE0000205)
  - [https://go.drugbank.com/drugs/DB00619#BE0000852](https://go.drugbank.com/drugs/DB00619#BE0000852)
  - [https://en.wikipedia.org/wiki/Chronic_eosinophilic_leukemia](https://en.wikipedia.org/wiki/Chronic_eosinophilic_leukemia)
  - [https://en.wikipedia.org/wiki/Eosinophilia#Chronic_eosinophilic_leukemia_(NOS)](https://en.wikipedia.org/wiki/Eosinophilia#Chronic_eosinophilic_leukemia_(NOS))
  - [https://en.wikipedia.org/wiki/Imatinib#Other](https://en.wikipedia.org/wiki/Imatinib#Other)
